Literature DB >> 32338527

Choroidal changes in intermediate age-related macular degeneration patients with drusen or pseudodrusen.

Raffaella Rosa1, Paolo Corazza1, Maria Musolino1, Chiara Mochi1, Guido Maiello2, Carlo Enrico Traverso1, Massimo Nicolò1,3.   

Abstract

Reticular pseudodrusen are associated with a thinner choroid. The aim of our study was to determine the differences in central choroidal thickness and choriocapillaris vascular flow area between eyes with and without reticular pseudodrusen using swept-source optical coherence tomography and swept-source optical coherence tomography angiography. We conducted a retrospective case control study which included 27 eyes from 27 consecutive patients with intermediate age-related macular degeneration and 17 eyes from 17 healthy participants. Complete ophthalmic examinations were carried out including axial length measurements; fundus color retinography; fundus autofluorescence; swept-source optical coherence tomography and swept-source optical coherence tomography angiography; central choroidal thickness and choriocapillaris vascular flow area. Patients were classified as no reticular pseudodrusen, mild reticular pseudodrusen, and severe reticular pseudodrusen. Mean central choroidal thickness in patients exhibiting severe reticular pseudodrusen (110 ± 56 μm) was significantly smaller than in patients with no reticular pseudodrusen (201 ± 76 μm, p < 0.01). Mean choriocapillaris vascular flow area in severe reticular pseudodrusen patients (45.2% ± 3.0%) was also significantly less than in patients with no (47.9% ± 1.6%, p < 0.001) and mild reticular pseudodrusen (47.7% ± 1.0%, p < 0.05). Stepwise multiple regression models confirmed the association of reticular pseudodrusen with central choroidal thickness (p < 0.001) and choriocapillaris vascular flow area (p < 0.01) even after accounting for age, axial length, and refractive error. Soft drusen were not associated with changes in either central choroidal thickness (p = 0.13) nor choriocapillaris vascular flow area (p = 0.29). A significant, positive relationship was found between central choroidal thickness and choriocapillaris vascular flow area (r = 0.44, p = 0.01). Therefore, both central choroidal thickness and choriocapillaris vascular flow area are decreased in eyes with reticular pseudodrusen, as compared to healthy eyes and intermediate age-related macular degeneration eyes not exhibiting reticular pseudodrusen. In addition, central choroidal thickness and choriocapillaris vascular flow area are related, and the reduction of either is directly associated to the severity of reticular pseudodrusen. Further studies are needed to assess the clinical significance of these findings.

Entities:  

Keywords:  Age-related macular degeneration; anatomy/biochemistry/physiology; choroidal ischemia; retina; techniques of retinal examination; uvea

Mesh:

Year:  2020        PMID: 32338527     DOI: 10.1177/1120672120914530

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

1.  Gender as an effect modifier in the relationship between hypertension and reticular pseudodrusen in patients with early or intermediate age-related macular degeneration.

Authors:  Nathaniel Gelinas; Anne M Lynch; Marc T Mathias; Alan G Palestine; Naresh Mandava; Karen L Christopher; Jennifer L Patnaik
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

2.  Reticular Pseudodrusen Are Associated With More Advanced Para-Central Photoreceptor Degeneration in Intermediate Age-Related Macular Degeneration.

Authors:  Matt Trinh; Natalie Eshow; David Alonso-Caneiro; Michael Kalloniatis; Lisa Nivison-Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

3.  Genetic and environmental risk factors for reticular pseudodrusen in the EUGENDA study.

Authors:  Lebriz Altay; Sandra Liakopoulos; Aileen Berghold; Kerstin-Daniela Rosenberger; Angela Ernst; Anita de Breuk; Anneke I den Hollander; Sascha Fauser; Tina Schick
Journal:  Mol Vis       Date:  2021-12-31       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.